• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Aphena Pharma Announces Massive Expansion in Tennessee

Share:

September 28, 2020

Aphena Pharma Solutions announces a $21 million expansion of its Solid Dose Division in Cookeville, Tennessee, with the acquisition of a 500,000-square-foot property, purpose-built for FDA manufacturing and packaging operations.

Aphena has already begun renovation to transform the property into a state-of-the-art pharmaceutical packaging and distribution facility. The renovations will be completed by Feb. 1, 2021, with an August 2020 operations start at the new facility, where Aphena’s corporate headquarters will be located.

This acquisition, which will add 258,000 square feet to Aphena’s current Cookeville footprint, also represents the company’s expansion into biologics, cold chain storage and third-party logistics distribution.

“This new facility will make Aphena a top contender in the pharmaceutical contract service space, starting with over 12,000 pallets of cold chain storage capacity,” said Eric Allen, Aphena’s EVP of Sales. “Being able to offer turnkey packaging and distribution services for biologic products, plus expanding the current operations with newly innovated bottling and packaging lines, will continue to attract key pharmaceutical customers to the Middle Tennessee area.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The current operation expansion will allow Aphena to install 24 high-speed bottling lines and eight thermoform blister packaging lines. In addition, the 200,000-plus square feet of warehouse space provides a strong foundation for a new, third-party logistics program for current and future customers.

“This expansion is exciting news for Aphena, our customers and our communities,” said Aphena CEO Shawn Reilley. “The Solid Dose Division and recent Liquids Division expansions will establish Aphena’s position as one of the most diversified manufacturing and packaging companies in the pharmaceutical industry. These growth strategies will continue to offer our customers expanded project capabilities at every level, and it will create a very large employment opportunity, both in Cookeville and at our facility in Easton, Maryland.”

Aphena Pharma Solutions is an industry-leading organization providing contract manufacturing and packaging services for the biologics, pharmaceutical, consumer health and medical device markets. With two separate FDA- and DEA-registered locations in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotion-based products.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • KLAS Reveals Vendors Learning to Mitigate Negative ImpactKLAS Reveals Vendors Learning to Mitigate Negative Impact
  • Game Changing Startups 2019Game Changing Startups 2019
  • UK Medical 3D Printing Startup axial3D Lands $3M to Assist US EnlargementUK Medical 3D Printing Startup axial3D Lands $3M to Assist US Enlargement
  • Envisioning a 5G-Powered Retail-Healthcare HubEnvisioning a 5G-Powered Retail-Healthcare Hub
  • Bigfoot Biomedical Caps off its Series C Funding at $55M, Including a New $10M AdditionBigfoot Biomedical Caps off its Series C Funding at $55M, Including a New $10M Addition
  • CSL Tenders Offer to Buy Vifor Pharma for $11.7 BillionCSL Tenders Offer to Buy Vifor Pharma for $11.7 Billion
  • Immunome to Acquire Antibody-Related Assets and Materials from AtrecaImmunome to Acquire Antibody-Related Assets and Materials from Atreca
  • IGC Pharma Announces a $3 Million Private Placement of its Common StockIGC Pharma Announces a $3 Million Private Placement of its Common Stock

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications